1 |
Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702
DOI
|
2 |
Kim SJ, Kim CH, Sohn YM, Lew WJ. Kang MK. Prevalence survey of lymphadenitis after BCG vaccination. Program and Abstract, the 48th Annual Fall Meeting of the Korean Pediatric Society; 1998 Oct 16-17; Seoul. Seoul : The Korean Pediatric Society, 1998:69
|
3 |
Jin BW, Hong YP, Kim SJ. A contact study to evaluate the BCG vaccination programme in Seoul. Tubercle 1989; 70:241-8
DOI
ScienceOn
|
4 |
Kim HI, Baik HG. Clinical analysis of lymphadenitis after BCG vaccination. J Korean Surg Soc 1995;49:417-24
|
5 |
Merry C, Fitzgerald RJ. Regional lymphadenitis following BCG vaccination. Pediatr Surg Int 1996;11:269-71
DOI
|
6 |
Hengster P, Schnapka J, Fille M, Menardi G. Occurrence of suppurative lymphadenitis after a change in BCG vaccination. Arch Dis Child 1992;67:952-5
DOI
ScienceOn
|
7 |
Kim KH, Lee SJ, Lee K. PPD conversion rate and complications according to the different time of BCG vaccination. J Korean Pediatr Soc 1987;30:487-90
|
8 |
Teo SS, Smeulders N, Shingadia DV. BCG vaccine-associated suppurative lymphadenitis. Vaccine 2005;23:2676-9
DOI
ScienceOn
|
9 |
Na KH, Rim SS, Kim EY, Kim KS, Kim YW. Factors affecting clinical course of BCG lymphadenitis. Korean J Pediatr Infect Dis 2001;8:181-90
DOI
|
10 |
Caglayan S, Yegin O, Kayran K, Timocin N, Kasirga E, Gun M. Is medical therapy effective for regional adenitis following BCG vaccination- Am J Dis Child 1987;141:1213-4
|
11 |
Park IS, Han DK, Lim HJ, Oh SH. Lee H. Comparison of Tuberculin skin test results and adverse reactions following BCG vaccination in various infant groups of different ages. J Korean Pediatr Soc 1993;36:1300-7
|
12 |
Wasz-Hockert O, Backman A, Lotte A. Osteitis caused by BCG vaccination of newborn. Bull Int Union Tuberc 1979; 54:325-31
|
13 |
Lotte A, Wazs-Hockert O, Poisson N, Engbaek H, Landmann H, Quast U, et al. Second IUALTD study on complications induced by intradermal BCG vaccination. Bull Int Union Tuberc Lung Dis 1988;63:47-59
|
14 |
Noah PK, Pande D, Johson B, Ashley D. Evaluation of oral erythromycin and local isohiasic instillation therapy in infants with Bacillus Camette-Guerin lymphadenitis and abscess. Pediatr Infect Dis J 1993;12:136-9
DOI
ScienceOn
|
15 |
Moreno L, Gottrand F, Herbaux B, Savage C, Ferriaux JP. Vertebral osteitis following BCG vaccination in a previously healthy child. Eur J Pediatr 1990;149:668.
DOI
ScienceOn
|
16 |
Bergdahl S, Fellander M, Robertson B. BCG osteomyelitis. Experience in Stockholm region over the 1961-74. J Bone Joint Surg 1976;58:212-6.
|
17 |
Ministry of Health and Welfare, The Korean Institute of Tuberculosis. The 7th national tuberculosis prevalence survey in 1995 in Korea. 1995:8-12
|
18 |
The WHO Position Paper on BCG Vaccine. Weeakly Epidemiological Record 2004;79:27-38.
|
19 |
Kroger L, Brander E, Korppi M, Wasz-Hockert O, Backman A, Kroger H, et al. Osteitis after newborn vaccination with three different Bacillus Calmette-Guerin vaccines : twenty-nine years of experience. Pediatr Infect Dis J 1994; 13:113-6
DOI
ScienceOn
|
20 |
Stuckey J. Prevalence of BCG-related adenitis in healthy children, Maputo Ctiy, Mozamgique. UNICEF report October 1988
|
21 |
Lotte A, Watz-Hockert O, Poisson N. Dumitrescu N, Verron M, Couvet E. BCG complications : Estimates of the risk among vaccinated subjects and statistical analysis of their characteristics. Adv Tuberc Res 1984;21:107-93
|
22 |
Oguz F, Mujgan S, Alper G, Alev F, Neyzi O. Treatment of Bacillus Camette-Guerin associated lymphadenitis. Pediatr Infect Dis J 1992;11:887-8
DOI
ScienceOn
|
23 |
Oh JT, Kim IG, Han SJ, Hwang EH. Management of BCG lymphadenitis. J Korean Assoc Pediatr Surg 1997;3:143-7
|
24 |
The Korean Pediatric Society. General recommendations on immunizations. 5th ed. Seoul : Kwang Moon Co, 2002:35-47
|
25 |
Hwang JS, Choi YY, Ma JS, Hwang TJ. A clinical study on BCG lymphadenitis. J Korean Pediatr Soc 1997;40:614-8
|
26 |
Ministry of Health and Welfare, Adverse events and management following BCG vaccination. Document No. 655 1995:40-818
|
27 |
Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO : a review of factors that my influence vaccine effectiveness and safety. Bull World Health Organ 1990;68:93- 108
|